Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
Plos One
|
August 5, 2014
Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction
Naoya Uchida, Matthew M Hsieh, Charlotte Platner, et al.
Stem Cells (Dayton, Ohio)
|
February 12, 2016
β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs
Atsushi Fujita, Naoya Uchida, Juan J Haro-Mora, et al.
Advances in Experimental Medicine and Biology
|
February 5, 2019
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Selami Demirci, Alexis Leonard, Juan J Haro-Mora, et al.
Cells
|
June 10, 2022
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Paula Germino-Watnick, Malikiya Hinds, Anh Le, et al.
Cell Stem Cell
|
February 5, 2021
Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Claire M Drysdale, Tina Nassehi, Jackson Gamer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 14, 2010
Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector
Naoya Uchida, Kareem N Washington, Coen J Lap, et al.
Experimental Hematology
|
October 27, 2015
Kinetics of lentiviral vector transduction in human CD34(+) cells
Naoya Uchida, Rashidah Green, Josiah Ballantine, et al.
Stem Cells Translational Medicine
|
February 9, 2020
Biallelic correction of sickle cell disease-derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum-free iPS-sac/erythroid differentiation
Juan J Haro-Mora, Naoya Uchida, Selami Demirci, et al.
Cytotherapy
|
December 1, 2019
Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
Lydia N Raines, Matthew M Hsieh, Tina Nassehi, et al.
International Journal of Hematology
|
November 23, 2006
Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression
Mitsuharu Inami, Koiti Inokuchi, Hiroki Yamaguchi, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
Plos One
|
August 5, 2014
Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction
Naoya Uchida, Matthew M Hsieh, Charlotte Platner, et al.
Stem Cells (Dayton, Ohio)
|
February 12, 2016
β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs
Atsushi Fujita, Naoya Uchida, Juan J Haro-Mora, et al.
Advances in Experimental Medicine and Biology
|
February 5, 2019
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Selami Demirci, Alexis Leonard, Juan J Haro-Mora, et al.
Cells
|
June 10, 2022
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Paula Germino-Watnick, Malikiya Hinds, Anh Le, et al.
Cell Stem Cell
|
February 5, 2021
Hematopoietic-Stem-Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Claire M Drysdale, Tina Nassehi, Jackson Gamer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 14, 2010
Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector
Naoya Uchida, Kareem N Washington, Coen J Lap, et al.
Experimental Hematology
|
October 27, 2015
Kinetics of lentiviral vector transduction in human CD34(+) cells
Naoya Uchida, Rashidah Green, Josiah Ballantine, et al.
Stem Cells Translational Medicine
|
February 9, 2020
Biallelic correction of sickle cell disease-derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum-free iPS-sac/erythroid differentiation
Juan J Haro-Mora, Naoya Uchida, Selami Demirci, et al.
Cytotherapy
|
December 1, 2019
Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
Lydia N Raines, Matthew M Hsieh, Tina Nassehi, et al.
International Journal of Hematology
|
November 23, 2006
Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression
Mitsuharu Inami, Koiti Inokuchi, Hiroki Yamaguchi, et al.
Page
of 9